• Discover how HD-MEA technology accelerates neuroscientific research, delivering insights into disease phenotypes and drug screening.
• See its use across human iPSC models - from cultures and spheroids to brain organoids.
• Gain deeper understandings of neuronal and brain organoid maturation, and investigate the functional effects of neuroactive drugs.
Or investigate brain organoid responses to specific compounds
HD-MEAs provide the resolution and sensitivity needed to study how brain organoids react to drugs or other compounds. This opens the door for novel iPSC-based discoveries and more predictive drug screening.
CorePlate™enables the precise analysis of brain organoid responses to compounds, as demonstrated with ACROBiosystems Human iPSC Derived Cerebral Organoids.
In collaboration with ACROBiosystemsOr access data from deep within your brain organoid
With 3D electrodes that penetrate the inner layers of brain organoids, you can obtain robust recordings from regions previously out of reach. Curious about how effective this is? Check out the new
publication from Mapelli et al., and join us at our lunch and learn to explore how this could help advance your brain organoid research.
Open to scientists across biotech and pharma
This Lunch & Learn offers practical insights and new perspectives on leveraging HD-MEA technology in neuroscience and drug screening. Explore real-world applications, from neuronal hiPSC cultures, to spheroids and brain organoids.
Join us to discover how HD-MEA delivers high-resolution data for in-depth network analysis at single-cell resolution, helping you drive your neuroscience and drug screening to the next level.
.svg)
